Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MULTIPLE SCLEROSIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06065670
What this trial is testing

Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy

Who this might be right for
Demyelinating DiseasesDemyelination; Corpus CallosumMultiple Sclerosis Brain Lesion+2 more
University of California, San Francisco 44
Testing effectiveness (Phase 2)Ended earlyNCT04326283
What this trial is testing

Trial of Safety, Tolerability and Efficacy of Trametinib (SNR1611) in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Genuv Inc. 23
Large-scale testing (Phase 3)WithdrawnNCT03172741
What this trial is testing

The Effects of Different Medical Marijuana Strains on Motor and Cognitive Function in People With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Colorado State University
Not applicableEnded earlyNCT04599023
What this trial is testing

Assessing the Feasibility of the MSPT Device in Routine Clinical Practice in the Swiss Healthcare System

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
Insel Gruppe AG, University Hospital Bern 182
Testing effectiveness (Phase 2)Looking for participantsNCT03109288
What this trial is testing

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

Who this might be right for
Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 250
Not applicableStudy completedNCT01947582
What this trial is testing

The Effects of Ankle Foot Orthoses (AFOs) on Mobility in Persons With Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
University of Texas Southwestern Medical Center 2
Testing effectiveness (Phase 2)Study completedNCT00202982
What this trial is testing

Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose

Who this might be right for
Relapse-Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 90
Not applicableLooking for participantsNCT06949696
What this trial is testing

Effect of Dual-Task Training and Cognitive Rehabilitation in Individuals With Multiple Sclerosis.

Who this might be right for
Multiple Sclerosis
Toros University 30
Not applicableStudy completedNCT06868342
What this trial is testing

Nerve Root Block in Spasticity

Who this might be right for
SpasticitySpasticity in Participants With Multiple SclerosisSpasticity Post Stroke+1 more
Walton Centre NHS Foundation Trust 4
Not applicableUnknownNCT06197841
What this trial is testing

Neurofilament Light Chain as Diagnostic and Prognostic Marker in naïve Multiple Sclerosis Patients

Who this might be right for
Role of Neurofilment in Diagnosis of Multiple Sclerosis
Assiut University 85
Testing effectiveness (Phase 2)Study completedNCT00228397
What this trial is testing

Study Evaluating CCI-779 in Relapsing Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Wyeth is now a wholly owned subsidiary of Pfizer 221
Testing effectiveness (Phase 2)Ended earlyNCT01039103
What this trial is testing

Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)

Who this might be right for
Acute Exacerbation of Remitting Relapsing Multiple SclerosisClinically Isolated Syndrome
Lakefront Biotherapeutics NV 15
Not applicableLooking for participantsNCT07580820
What this trial is testing

Gait Adaptability in Persons With MS Having Mild Disability

Who this might be right for
Multiple SclerosisHealthy Adults
Hasselt University 32
Not applicableUnknownNCT02098759
What this trial is testing

Long-term, Prospective Study Evaluating Clinical and Molecular Biomarkers of Epileptogenesis in a Genetic Model of Epilepsy - Tuberous Sclerosis Complex

Who this might be right for
TSCTuberous Sclerosis ComplexEpilepsy
Sergiusz Jozwiak 100
Early research (Phase 1)UnknownNCT04178980
What this trial is testing

Role of Simvastatin in Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Simvastatin Multiple Sclerosis
Assiut University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06453694
What this trial is testing

Efgartigimod for the Treatment of Acute Optic Neuritis

Who this might be right for
Optic Neuritis
Anastasia Vishnevetsky, MD, MPH 20
Post-approval studies (Phase 4)Study completedNCT00913666
What this trial is testing

Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers

Who this might be right for
Multiple Sclerosis
Biogen 121
Testing effectiveness (Phase 2)Ended earlyNCT04494256
What this trial is testing

Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation

Who this might be right for
Amyotrophic Lateral Sclerosis
Biogen 99
Not applicableStudy completedNCT02851342
What this trial is testing

GTA-MEG as a Biomarker for Cognition in MS

Who this might be right for
Multiple Sclerosis
Universitair Ziekenhuis Brussel 159
Not applicableStudy completedNCT05661266
What this trial is testing

Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Innodem Neurosciences 120
Next Page